Chapter 18
Atopic Dermatitis
Complications
Kevin B. Yarbrough,
Eric L. Simpson,
Kevin B. Yarbrough
Department of Pediatric Dermatology, Phoenix Children's Hospital, Phoenix, AZ, USA
Search for more papers by this authorEric L. Simpson
Department of Dermatology, Oregon Health and Science University, Portland, OR, USA
Search for more papers by this authorKevin B. Yarbrough,
Eric L. Simpson,
Kevin B. Yarbrough
Department of Pediatric Dermatology, Phoenix Children's Hospital, Phoenix, AZ, USA
Search for more papers by this authorEric L. Simpson
Department of Dermatology, Oregon Health and Science University, Portland, OR, USA
Search for more papers by this authorBook Editor(s):Peter Hoeger,
Veronica Kinsler,
Albert Yan,
John Harper,
Arnold Oranje,
Christine Bodemer,
Margarita Larralde,
David Luk, Vibhu Mendiratta,
Diana Purvis,
Peter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorFirst published: 20 November 2019
Summary
Complications of atopic dermatitis (AD) include both cutaneous and extracutaneous conditions. Acute cutaneous complications include both bacterial and viral infections that have unique presentations in children with AD. Extracutaneous complications of AD include not only the classic atopic comorbidities like asthma and hay fever, but also extend to ocular problems, sleep disturbance and mental health conditions. Recognizing the array of potential comorbid conditions enables the clinician to work with consultants to treat the whole patient.
References
- Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90: 525–30.
- Totté JE, van der Feltz WT, Hennekam M et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2016; 175: 687–95.
- Bonness S, Szekat C, Novak N, Bierbaum G. Pulsed-field gel electrophoresis of Staphylococcus aureus isolates from atopic patients revealing presence of similar strains in isolates from children and their parents. J Clin Microbiol 2008; 46: 456–61.
- Klein PA, Greene WH, Fuhrer J, Clark RA. Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol 1997; 133: 1463–5.
- Chung HJ, Jeon HS, Sung H et al. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J Clin Microbiol 2008; 46: 991–5.
- Matiz C, Tom WL, Eichenfield LF et al. Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience. Pediatr Dermatol 2011; 28: 6–11.
- Hayashida S, Furusho N, Uchi H et al. Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis? J Dermatol Sci 2010; 60: 173–8.
- Benenson S, Zimhony O, Dahan D et al. Atopic dermatitis—a risk factor for invasive Staphylococcus aureus infections: two cases and review. Am J Med 2005; 118: 1048–51. Review.
- Hoeger PH, Ganschow R, Finger G. Staphylococcal septicemia in children with atopic dermatitis. Pediatr Dermatol 2000; 17: 111–14.
- Onoda K, Mizutan H, Komada T et al. Atopic dermatitis as a risk factor for acute native valve endocarditis. J Heart Valve Dis 2000; 9: 469–71.
- Kong HH, Oh J, Deming C et al; NISC Comparative Sequence Program, Murray PR, Turner ML, Segre JA. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22: 850–9.
- Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001; 108: 269–74.
- Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151–60.
- Howell MD, Boguniewicz M, Pastore S et al. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 2006; 121: 332–8.
- Brauweiler AM, Goleva E, Leung DY. Th2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6). J Invest Dermatol 2014; 134: 2114–21.
- Warner JA, McGirt LY, Beck LA. Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis. Br J Dermatol 2009; 160: 183–5.
- Cai SC, Chen H, Koh WP et al. Filaggrin mutations are associated with recurrent skin infection in Singaporean Chinese patients with atopic dermatitis. Br J Dermatol 2012; 166: 200–3.
- Lopes C, Rocha L, Sokhatska O et al. Filaggrin polymorphism Pro478Ser is associated with the severity of atopic dermatitis and colonization by Staphylococcal aureus. J Investig Allergol Clin Immunol 2016; 26: 70–2.
-
Lebon A, Labout JA, Verbrugh HA et al. Role of Staphylococcus aureus nasal colonization in atopic dermatitis in infants: the Generation R Study. Arch Pediatr Adolesc Med 2009;163:745–9. Erratum in: Arch Pediatr Adolesc Med 2010; 164: 334.
10.1001/archpediatrics.2010.27 Google Scholar
- Akdis M, Simon HU, Weigl L et al. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999; 163: 466–75.
- Bantel H, Sinha B, Domschke W et al. alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol 2001; 155: 637–48.
- Williams MR, Nakatsuji T, Sanford JA et al. Staphylococcus aureus induces increased serine protease activity in keratinocytes. J Invest Dermatol 2017; 137: 377–84.
- Hirasawa Y, Takai T, Nakamura T et al. Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction. J Invest Dermatol 2010; 130: 614–17.
- Hon KL, Tsang YC, Pong NH et al. Clinical features and Staphylococcus aureus colonization/infection in childhood atopic dermatitis. J Dermatolog Treat 2016; 27: 235–40.
- Simpson EL, Babineau D, Villarreal M et al. S. aureus colonization is associated with impaired skin barrier function and greater Th2 activation in adult subjects with AD. J Invest Dermatol 2016; 136: S56.
- Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol 2010; 163: 12–26.
- Huang JT, Abrams M, Tlougan B et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123: e808–14.
- Wong SM, Ng TG, Baba R. Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia. J Dermatol 2013; 40: 874–80.
- Gonzalez ME, Schaffer JV, Orlow SJ et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol 2016; 75: 481–93.e8.
- Leung TH, Zhang LF, Wang J et al. Topical hypochlorite ameliorates NF-kB-mediated skin diseases in mice. J Clinc Invest 2013; 123: 5361–70.
References
- Naleway AL, Belongia EA, Greenlee RT et al. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med 2003; 139: 1–7.
- Moses AE, Cohen-Poradosu R. Images in clinical medicine. Eczema vaccinatum—a timely reminder. N Engl J Med 2002; 346: 1287.
- Vora S, Damon I, Fulginiti V et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis 2008; 46: 1555–61.
- Tay YK, Khoo BP, Goh CL. The epidemiology of atopic dermatitis at a tertiary referral skin center in Singapore. Asian Pac J Allergy Immunol 1999; 17: 137–41.
- Beck LA, Boguniewicz M, Hata T et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 2009; 124: 260–9, 9.e1–7.
- Gao PS, Rafaels NM, Hand T et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 2009; 124: 507–13, 513.e1–7.
- Leung DY, Gao PS, Grigoryev DN et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response. J Allergy Clin Immunol 2011; 127: 965–73.e1–5. Erratum in: J Allergy Clin Immunol 2011;128:833.
- Takahashi R, Sato Y, Kurata M et al. Pathological role of regulatory T cells in the initiation and maintenance of eczema herpeticum lesions. J Immunol 2014; 192: 969–78.
- Gao L, Bin L, Rafaels NM et al. Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol 2015; 136: 1591–600.
- Mathes EF, Oza V, Frieden IJ et al. “Eczema coxsackium” and unusual cutaneous findings in an enterovirus outbreak. Pediatrics 2013; 132: e149–57.
- Luca NJ, Lara-Corrales I, Pope E. Eczema herpeticum in children: clinical features and factors predictive of hospitalization. J Pediatr 2012; 161: 671–5.
- Jordan R, Leeds JM, Tyavanagimatt S, Hruby DE. Development of ST-246® for treatment of poxvirus infections. Viruses 2010; 2: 2409–35.
References
- Camfferman D, Kennedy JD, Gold M et al. Eczema and sleep and its relationship to daytime functioning in children. Sleep Med Rev 2010; 14: 359–69.
- Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S et al. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995; 149: 856–60.
- Reuveni H, Chapnick G, Tal A, Tarasiuk A. Sleep fragmentation in children with atopic dermatitis. Arch Pediatr Adolesc Med 1999; 153: 249–53.
- Bender BG, Leung SB, Leung DY. Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure. J Allergy Clin Immunol 2003; 111: 598–602.
- Camfferman D, Kennedy JD, Gold M et al. Sleep and neurocognitive functioning in children with eczema. Int J Psychophysiol 2013; 89: 265–72.
- Stores G, Burrows A, Crawford C. Physiological sleep disturbance in children with atopic dermatitis: a case control study. Pediatr Dermatol 1998; 15: 264–8.
- Monti JM, Vignale R, Monti D. Sleep and nighttime pruritus in children with atopic dermatitis. Sleep 1989; 12: 309–14.
- Chamlin SL, Mattson CL, Frieden IJ et al. The price of pruritus: Sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med 2005; 159: 745–50.
- Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010; 64: 269–73.
- Stewart AC, Thomas SE. Hypnotherapy as a treatment for atopic dermatitis in adults and children. Br J Dermatol 1995; 132: 778–83.
- Klein PA, Clark RF. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135: 1522–5.
- Sidbury R, Tom WL, Bergman JN et al. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol 2014; 71: 1218–33.
- Endo K, Sano H, Fukuzumi T et al. Objective scratch monitor evaluation of the effect of an antihistamine on nocturnal scratching in atopic dermatitis. J Dermatol Sci 1999; 22: 54–61.
- Schad CA, Skoner DP. Antihistamines in the pediatric population: Achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria. Allergy Asthma Proc 2008; 29: 7–13.
- Chang Y-S, Lin M-H, Lee J-H et al. Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial. JAMA Pediatr 2016; 170: 35.
- Sowden JM, Allen BR, Berth-Jones J et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. The Lancet 1991; 338: 137–40.
- Leo HL, Bender BG, Leung SB et al. Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis. J Allergy Clin Immunol 2004; 114: 691–3.
- Bieber T, Vick K, Fölster-Holst R et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 184–9.
References
- King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 1991; 35: 697–706.
- Absolon CM, Cottrell D, Eldridge SM, Glover MT. Psychological disturbance in atopic eczema: the extent of the problem in school-aged children. Br J Dermatol 1997; 137: 241–5.
- Saunes M, Smidesang I, Holmen TL, Johnsen R. Atopic dermatitis in adolescent boys is associated with greater psychological morbidity compared with girls of the same age: the Young-HUNT study. Br J Dermatol 2007; 156: 283–8.
- Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993; 69: 670–6.
- Chamlin SL, Frieden IJ, Williams ML, Chren M-M. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004; 114: 607–11.
- Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008; 25: 1–6.
- Fivenson D. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002; 8: 333–42.
- Ersser SJ, Cowdell F, Latter S et al. Psychological and educational interventions for atopic eczema in childrenCochrane Database Syst Rev 2014; CD004054.
- Staab D. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006; 332: 933–8.
- Chida Y, Steptoe A, Hirakawa N et al. The effects of psychological intervention on atopic dermatitis. Int Arch Allergy Immunol 2007; 144: 1–9.
References
- Brunsting LA. Atopic dermatitis (disseminated neurodermatitis) of young adults: analysis of precipitating factors in one hundred and one cases and report of ten cases with associated juvenile cataract. Arch Derm Syphilol 1936; 34: 935–57.
- Faulstich ME, Williamson DA, Duchmann EG et al. Psychophysiological analysis of atopic dermatitis. Jo Psychosom Res 1985; 29: 415–17.
- Absolon CM, Cottrell D, Eldridge SM, Glover MT. Psychological disturbance in atopic eczema: the extent of the problem in school-aged children. Br J Dermatol 1997; 137: 241–5.
- Chamlin SL. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther 2006; 19: 104–7.
- Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993; 69: 670–6.
- Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 2010; 65: 1506–24.
- Yaghmaie P, Koudelka CW, Simpson EL. Psychiatric comorbidity in pediatric eczema. J Invest Dermatol 2011; 131(suppl 1): S41. Abstract #246.
- Magalhaes ES, Pinto-Mariz F, Bastos-Pinto S et al. Immune allergic response in Asperger syndrome. J Neuroimmunol 2009; 216(1-2): 108–12.
- Mostofa GA, Hamza RT, El-Shahawi HH. Allergic manifestations in autistic children: Relation to disease severity. J Pediatr Neurol 2008; 6: 115–23.
- Sacco R, Curatolo P, Manzi B et al. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res 2010; 3: 237–52.
- Yokomaku A, Misao K, Omoto F et al. A study of the association between sleep habits and problematic behaviors in preschool children. Chronobiol Int 2008; 25: 549–64.
- Hiscock H, Canterford L, Ukoumunne OC, Wake M. Adverse associations of sleep problems in Australian preschoolers: national population study. Pediatrics 2007; 119: 86–93.
- Gregory AM, Van der Ende J, Willis TA, Verhulst FC. Parent-reported sleep problems during development and self-reported anxiety/depression, attention problems, and aggressive behavior later in life. Arch Pediatr Adolesc Med 2008; 162: 330–5.
- Owens JA, Maxim R, Nobile C et al. Parental and self-report of sleep in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2000; 154: 549–55.
- Ivanenko A, Johnson K. Sleep disturbances in children with psychiatric disorders. Semin Pediatr Neurol 2008; 15: 70–8.
- Buehler MR. A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder. Med Hypotheses 2011; 76: 863–70.
- Kiecolt-Glaser JK, Belury MA, Andridge R et al. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 2011; 25: 1725–34.
- Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 2002; 5: 389–99.
- Zimmerman AW, Jyonouchi H, Comi AM et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 2005; 33: 195–201.
References
- Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: A review. J Am Acad Dermatol 2014; 70: 569–75.
- Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol 2010; 10: 478–85.
- Carmi E, Defossez-Tribout C, Ganry O et al. Ocular complications of atopic dermatitis in children. Acta Derm Venereol 2006; 86: 515–17.
- Rich LF, Hanifin JM. Ocular complications of atopic dermatitis and other eczemas. Int Ophthalmol Clin 1985; 25: 61–76.
- Bonini S, Bonini S, Lambiase A et al. Vernal keratoconjunctivitis revisited: A case series of 195 patients with long-term followup. Ophthalmology 2000; 107: 1157–63.
- Bair B, Dodd J, Heidelberg K, Krach K. Cataracts in atopic dermatitis: A case presentation and review of the literature. Arch Dermatol 2011; 147: 585–8.
-
Hirano S, Katoh N, Kishimoto S et al. Cataract in atopic dermatitis with facial involvement. J Dermatol Sci 1993; 6: 94.
10.1016/0923-1811(93)91259-W Google Scholar
- Niwa Y, Iizawa O. Abnormalities in serum lipids and leukocyte superoxide dismutase and associated cataract formation in patients with atopic dermatitis. Arch Dermatol 1994; 130: 1387–92.
- Garrity JA, Liesegang TJ. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984; 19: 21–4.
- Tm B, Ja B, Jm S. Atopic dermatitis: a case report and current clinical review of systemic and ocular manifestations. Optom St Louis Mo 2001; 72: 94–102.
- Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 1984; 28: 293–322.
- Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol 2000; 84: 834–6.
- Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42: 297–319.
- Hida T, Tano Y, Okinami S et al. Multicenter retrospective study of retinal detachment associated with atopic dermatitis. Jpn J Ophthalmol 2000; 44: 407–18.
- Yoneda K, Okamoto H, Wada Y et al. Atopic retinal detachment. Report of four cases and a review of the literature. Br J Dermatol 1995; 133: 586–91.
- Taniguchi H, Ohki O, Yokozeki H et al. Cataract and retinal detachment in patients with severe atopic dermatitis who were withdrawn from the use of topical corticosteroid. J Dermatol 1999; 26: 658–65.
- Oka C, Ideta H, Nagasaki H et al. Retinal detachment with atopic dermatitis similar to traumatic retinal detachment. Ophthalmology 1994; 101: 1050–4.
